NASHVILLE, Tenn. (WSMV) — Tennessee Attorney General Jonathan Skrmetti, along with other state attorneys general, is urging the Food and Drug Administration (FDA) to act against the sale of counterfeit and unsafe versions of popular weight loss and diabetes medications, including Ozempic, Wegovy, Mounjaro, and Zepbound.
“Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are selling dangerous fakes,” Skrmetti said. “These counterfeit drugs can be contaminated due to shady supply chains from countries like China, Turkey, and others. Some may even contain completely different drugs, but are packaged to look like GLP-1 medications.”
Skrmetti stressed that the high demand, along with the high costs and limited supply of GLP-1 drugs, is creating opportunities for fraudsters to exploit consumers. He added that counterfeit, untested drugs are flooding the market.
“These counterfeit drugs not only pose a risk to public health but also to our national security,” he said. “Reports show that fake GLP-1 medications from countries like India, Turkey, and China have entered the U.S. supply chain.”
The attorney general is urging the FDA to take charge of protecting the American drug supply and work with other federal and state agencies to shut down the production and distribution of counterfeit drugs.
